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Anaemia frequently occurs in association with an 
underlying condition and is linked to poor clinical 
outcomes. In school-aged children in sub-Saharan 
Africa, the prevalence of anaemia is reported to be 
high (affecting 25.4%).[1] There is, however, a notable 
paucity of data relating to haemoglobin (Hb) levels, onset and duration 
of anaemia, and the underlying illness causing the anaemia in school-
aged children. This is a significant deficiency, as any anaemia, even if it 
is mild, can compromise growth and development, irrespective of the 
underlying condition causing it. The Hb level is endorsed by the World 
Health Organization (WHO) as the universal indicator of anaemia 
at individual and population levels.[2] However, most reliable ways of 
measuring it require some automated equipment that is not readily 
available in primary healthcare centres or resource-poor settings.
An accurate diagnostic test is essential for identifying suboptimal 
Hb levels and monitoring the response to interventions. The HemoCue 
method has some key advantages over the routinely used laboratory 
method. The HemoCue device measures Hb in a small sample of undiluted 
capillary or venous blood, is portable and user friendly, does not require 
access to refrigeration or electricity, gives immediate digitally displayed 
results, and is relatively inexpensive. This study assessed the HemoCue as 
an alternative point-of-care (POC) test for diagnosing anaemia and as a 
potential vehicle to improve coverage for anaemia screening programmes. 
We also determined a practical initial diagnostic approach that could assist 
in selecting an appropriate management strategy.
Methods
Design and participants
We carried out a cross-sectional survey in a rural community living 
in an isolated mountainous part of western KwaZulu-Natal Province 
(KZN), South Africa. This study was an ancillary investigation in a 
larger longitudinal study measuring various health indicators and 
psychosocial needs of preschool and school-aged children. Data 
collection was integrated into the usual services at the research site 
as far as possible. One hundred and eighty-four consecutive children 
attending follow-up over a 4-month period were invited to take part 
in the current study.
Diagnostic testing
Hb values of children in this study were determined using two 
methods: the conventional laboratory method and the HemoCue 
device. Samples for the laboratory method and the HemoCue 
were collected simultaneously from the cephalic vein of seated 
participating children using a Vacutainer needle. Hb determination 
with the HemoCue was conducted at the research site by the principal 
investigator (TPG), who had received training on the standardised 
use of a portable HemoCue Hb-201+ system (Angelholm, Sweden). 
The child’s venous blood in the Vacutainer was used to fill a 
HemoCue cuvette and placed on the HemoCue. The result was read 
within 10 minutes and recorded to two decimal places. The device 
was calibrated each morning using the standard guideline provided. 
For every tenth participant, two HemoCue cuvettes were filled and 
the Hb values of the samples compared for quality control purposes. 
The HemoCue device readings were interpreted without knowledge 
of the results of the reference standard or clinical examination. 
Corresponding blood samples were sent for analysis according to 
standard protocol to a local accredited laboratory that measured Hb 
values using an automated analyser, the Siemens Advia 2120 machine. 
Anaemia cut-off values used were based on WHO recommen-
dations.[2] For the outcome measure of anaemia, Hb <11.5 g/dL was 
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used. Anaemia was classified as mild (Hb 
11.0 - 11.4 g/dL), moderate (8.0 - 10.9 g/dL) 
or severe (<8.0 g/dL).
Data management and analysis
Data were entered daily into a predesigned 
electronic database using the SPSS Statistics 
for Windows package, version 22.0 (IBM, 
USA), and cleaned regularly. SPSS was 
used to perform the statistical analysis. 
The distribution of Hb values was assessed 
using descriptive statistics and graphical 
plots. The paired Student’s t-test was used 
to compare mean Hb differences between 
the HemoCue device and the laboratory 
method. The intra-class correlation 
coefficient (ICC) and Pearson’s correlation 
coefficient were computed to assess the 
agreement and correlation between the Hb 
values provided by the two instruments. 
The Bland-Altman limits of agreement 
method was also applied to the numerical 
data to assess agreement between the two 
methods.[3] The Bland-Altman analysis was 
demonstrated in MS Excel. The sensitivity, 
specificity, positive predictive value (PPV) 
and negative predictive value (NPV) with 
95% confidence intervals (CIs) were used 
to determine diagnostic accuracy of the 
categorical data. Clinical intervention for 
anaemia is generally provided for cases 
with moderate and severe anaemia. Hence 
the assessment of HemoCue performance 
takes into consideration its ability to detect 
clinically significant anaemia with Hb 
values that are ≤10.9 g/dL according to the 
laboratory method.
Ethical considerations
Ethical approval for this study was obtained 
from the official review board of the 
University of KwaZulu-Natal Biomedical 
Research Ethics Committee. Informed 
consent was obtained from each child’s 
parent or caregiver before inclusion in the 
study. Children with anaemia were referred 
to their local health centre for further 
management.
Results
One hundred and eighty-four children 
participated in the study. The participants’ 
ages ranged from 72 to 102 months (mean 
83.7 (standard deviation (SD) 7.3)). There 
were more boys (108/184, 58.7%) than 
girls (76/184, 41.3%). The children all 
had symptoms of anaemia, and none were 
reported to be taking iron supplements.
The prevalence of anaemia using the 
laboratory method was 43/184 (23.4%) 
(mean Hb 12.17 g/dL, range 7.80 - 19.20; 95% 
CI  10.06 - 14.52). Anaemia was predomin-
antly mild (24/43, 55.8%) or moderate (18/43, 
41.9%). Severe anaemia was rare (1/43, 2.3%). 
According to the HemoCue device, the 
mean Hb was 11.70 g/dL (range 6.60 - 15.50; 
95% CI  9.45 - 14.13) and the prevalence of 
anaemia was 41.3% (76/184); 1/76 children 
(1.3%) had severe, 45/76 (59.2%) moderate 
and 30/76 (39.5%) mild anaemia.
Accuracy
The HemoCue device was generally precise 
and showed good correlation with the 
reference laboratory method (Figs 1 and 2); 
158/184 (85.9%) of Hb values measured with 
the HemoCue were within 1 g/dL of those 
measured with the laboratory reference 
method, and 182/184 (98.9%) were within 
2 g/dL.
The sensitivity for anaemia of the 
HemoCue device was 93%, meaning that 
only 7% of children with anaemia were 
missed by the device. The NPV was 97%, 
indicating that children with an optimal 
HemoCue reading were probably not 
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Fig. 1. Representation of linear regression of Hb concentrations between the HemoCue device and the 
laboratory method.
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Fig. 2. Bland-Altman representation of comparison analysis between the HemoCue device and the 
laboratory method.
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anaemic. Specificity was good (94%), 
but the PPV was low (52.6%), indicating 
that among the children with suboptimal 
HemoCue readings only 52.6% actually had 
the condition (Table 1).
Precision
The HemoCue device demonstrated good 
reproducibility. Generally no differences were 
observed between repeat procedures on the 
same sample of blood at the same time. 
Sequential samples in the same patient did not 
differ significantly. The mean difference for 
repeat HemoCue readings using the Bland-
Altman method was 0.1 g/dL (95% CI 0.1  - 
0.2). The 95% limits of agreement were –1.4 - 
1.5 g/dL. Instrument error was therefore ruled 
out as a substantial contributor of error due to 
unreliability.
The Bland-Altman mean difference for 
Hb values between the HemoCue device 
and the laboratory method was 0.47 g/dL 
(95% CI 0.36 - 0.59), with 95% limits of 
agreement ranging from –1.07 to 2.02 (Table 
2). The SD (precision 0.77) and Pearson 
correlation coefficient (r=0.79) were high 
and significant (p=0.000). The ICC was 0.88 
(95% CI 0.84 - 0.91). This was statistically 
significant (p=0.00). The ICC is calculated on 
a range of 0 - 1, with 1 representing complete 
reliability without any measurement errors 
and 0 reflecting unreliability.
Variation was noted in mean Hb values 
depending on anaemia status. The mean 
Hb for anaemic participants was 0.32 g/ dL 
(95% CI –0.51 - –0.14) with a Pearson 
correlation coefficient of r=0.81 and SD 0.60, 
and statistically significant (p=0.001). The 
standard error (SE) was low (0.092). The 
mean difference in Hb values among the 
non-anaemic participants was 0.52 g/dL (95% 
CI –0.66 - –0.39). The correlation among the 
non-anaemic participants was lower than 
among those who were anaemic (r=0.64, 
SD 0.81 and SE 0.068; p=0.000).
Discussion
This study showed that the HemoCue device 
was less accurate than the laboratory method 
and that its variability was significant. The 
hypothesis that the device is equivalent to 
the laboratory method has to be rejected. 
Nevertheless, it must be kept in mind that 
automated laboratory Hb analysis and the 
HemoCue are not competing techniques but 
complementary methods for Hb assessment. 
Laboratory analysis represents the gold-
standard reference method for Hb assessment. 
An acceptable mean difference between 
the HemoCue and the laboratory method 
would be <1 g/dL;[4] our results therefore 
show a significant difference (14.1%; p<0.05) 
between the two methods when monitoring 
Hb values. The relevance of this limit should 
be interpreted with caution, however, as a 1 g/
dL error will have different consequences for 
interpretation of Hb values depending on 
the circumstances. In evaluating the results 
of this study, one also needs to keep in 
mind the usefulness of the HemoCue as a 
POC anaemia screening tool that is portable, 
displays Hb results rapidly within 1 minute, 
and uses a tiny blood sample.
The HemoCue tended to underestimate 
Hb values compared with the laboratory 
method, which may result in overestimation 
of anaemia. Although the device gave 
lower Hb values, these measurements 
varied widely. Discrepancies in Hb values 
of >1.0  g/ dL were identified in 14.1% of 
participants and differences of >2 g/dL in 
1.1%. Outliers of >2  g/dL are significant 
because they could result in altered 
clinical management, with children being 
overtreated or over investigated. Although 
such large differences in Hb values were 
infrequent, we recommend that clinical 
decisions should not be based solely on 
HemoCue results.
While the differences noted could not 
definitely be attributed to any individual 
factor, they may be due to factors such 
as biological variation, collection mistakes 
during sampling, environmental factors or 
device error. Previous studies have generally 
reported a difference between the means, 
although most did not reach statistical sig-
nificance. The range in the mean difference 
of Hb values in this study was 0.1 - 0.5 g/ dL 
(SD 0.37 - 1.1). A trend towards underes-
timation of Hb values has frequently been 
reported,[5-7] although some studies found 
no difference,[8] some overestimation,[9] and 
another both under- and overestimation, 
Neufield et al.[10] reporting underestimation 
of Hb values with capillary samples for con-
centrations <12.5 g/ dL and overestimation at 
higher values.
The HemoCue device showed good 
sensitivity in detecting anaemia in the 
population studied (Table 2). Children with 
optimal Hb concentrations (>11.5 g/dL, 
the anaemia cut-off) are more likely to be 
misclassified than those with low values. The 
accuracy of the HemoCue was not affected 
by the presence of anaemia, although bias 
increased in non-anaemic participants with 
increasing Hb values. The mean difference 
in Hb values among non-anaemic children 
was 0.52 g/dL and that among anaemic 
children 0.32 g/dL. The sensitivity of the 
HemoCue for detecting anaemia was 93%, 
and the NPV was 97.22%. These values 
are near the top of the range reported in 
earlier studies, where sensitivity ranged from 
75% to 91%, specificity from 88% to 100%, 
and PPVs from 75% to 86%.[11] Differences 
in anaemia detection and estimates of 
severity could influence statistical estimates 
in screening initiatives and surveys. When 
screening for anaemia, a high sensitivity as 
Table 1. Performance of the HemoCue 
device in detecting anaemia and severe 
anaemia relative to the laboratory method
HemoCue 
performance
n/N (%)
Anaemia detection
Sensitivity 40/43 (93.0)
Specificity 105/141 (74.5)
PPV 40/76 (52.6)
NPV 105/108 (97.2)
Anaemia severity
Sensitivity 18/19 (94.7)
Specificity 138/165 (83.6)
PPV 18/45 (40.0)
NPV 138/139 (99.3)
Table 2. Diagnostic accuracy and precision of the HemoCue device
HemoCue Laboratory analyser
Hb (g/dL), mean 11.70 12.17 
Range (g/dL) 6.6 - 15.5 7.8 - 19.20
SD 0.189 0.187
SE 0.088 0.087
Mean difference (g/dL) 0.47 – statistically significant
Coefficient of variation 1.63 – wide variation 
95% limit of agreement –1.07 - 2.02
SD (g/dL) (precision)  0.77 
Discrepancies >1 g/dL, % of cases 14.1
Discrepancies >2 g/dL, % of cases 1.1
RESEARCH
599       July 2015, Vol. 105, No. 7
opposed to a high specificity is desirable, because poor outcomes are 
likely with untreated chronic anaemia. Although the HemoCue did 
not match the laboratory method, it can be expected to be useful as 
a screening tool and a reliable predictor of the need for a laboratory 
full blood count (FBC) in resource-poor populations. An FBC may 
be essential when anaemia is identified or iron deficiency is suspected 
in the presence of a normal HemoCue Hb reading. It is unlikely 
that clinically important anaemia will go unnoticed, either by the 
clinician or by the HemoCue. The HemoCue would therefore seem 
to be a useful screening method for anaemia in appropriate situations 
such as in primary healthcare, routine surveillance, field survey 
operations, or evaluation of interventions for iron nutrition.
The HemoCue device was not expected to match the laboratory 
gold-standard method, but simply to provide an alternative technique 
in prescribed circumstances. The Clinical Laboratories Improvement 
Act of 1988 recommends that the estimated percentage difference 
between a number of devices measuring Hb levels in a laboratory 
setting should be about 7% of the actual value.[12] We found a very 
high coefficient of variation (1.63) for the HemoCue, which was 
higher than that documented by other researchers investigating 
the performance of the device under fieldwork conditions.[11] The 
mean difference for Hb values was 0.47 g/dL and the 95% limits of 
agreement between the HemoCue and laboratory Hb values were 
–1.07 - 2.02 g/dL, indicating that the two measurement methods 
agreed closely in estimating small values but disagreed with larger 
values (Fig. 2). This finding suggests that for any child in this study 
population, the Hb assessments could have differed between –1.07 
and 2.02 g/dL. This is too wide-ranging to be clinically acceptable – 
it would mean, for example, that a child with an Hb value of 10 
g/dL according to the HemoCue would be expected to have a 
laboratory measurement between 8.93 and 12.02 g/dL. Both the ICC 
and Pearson’s correlation coefficient were determined, because it 
is possible to have a high degree of correlation while agreement is 
poor. We demonstrated a significant correlation (r=0.85; p=0.001) 
and a significant bias of 0.47 g/dL (SD 0.77) between the HemoCue 
and the laboratory method in a field setting (Table 2). Accordingly, 
data obtained from the field can be assumed to be of the same 
level of reliability as data obtained in laboratory settings. The 
diagnostic precision of the HemoCue in laboratory settings is widely 
acknowledged,[11] but its performance outside the laboratory setting 
has been questioned. Morris et al.[13] suggested the use of repeat 
sampling to minimise the effect of unreliability. However, this is 
unlikely to be practical during fieldwork and in settings where large 
numbers are surveyed.
Study limitations
This study analysed blood samples obtained from healthy children, 
so the results are limited to the screening of well children and should 
not be translated into a setting where acutely ill children need a 
reliable result and speedy intervention. The HemoCue test is widely 
conducted with a finger-prick capillary sample. In children, Hb levels 
between venous and capillary samples have been reported to vary, 
with the largest discrepancies being in the neonatal period and in 
acutely ill children. The largest difference between the two sample 
types has been observed in anaemic children.[10,11]
Recommendations
Studies have shown that iron deficiency anaemia can result in 
impaired psychomotor and behavioural development, which may 
not be reversible.[14] National screening of all children for anaemia 
during infancy and later when they start school may be a logical 
and productive approach to anaemia control. Screening of children 
around the stage of school entry gives an adequate time interval for 
anaemia of chronic disease to become apparent. The feasibility of 
routine large-scale screening of children for anaemia has not been 
investigated. Further studies are required to address this significant 
challenge. Until such screening investigations are implemented, the 
National Department of Health needs to highlight and endorse the 
appropriate execution of the Integrated Management of Childhood 
Illness programme for identification and management of anaemia in 
children. Our study suggests that the HemoCue test is comparable to 
the reference laboratory method as a practical technique for detecting 
anaemia in school-aged children. For the device to be used widely and 
successfully, the interpretation of Hb values may need to be adjusted. 
The definition of anaemia in children may be improved by basing it 
on an Hb range linked to negative potential health outcomes. This 
approach to defining anaemia may, however, result in larger numbers 
of children being categorised as anaemic. Further research is required 
before recommending this diagnostic approach, with studies that 
regulate confounding variables such as comorbidities.
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